Individuals with focal onset epilepsy treated with azetukalner experienced sustained monthly seizure reduction and evidence of seizure freedom up to 48 months, according to data presented at the ...

Many people living with focal onset seizures (FOS) fail to achieve seizure freedom, even after taking two or more ...

Please provide your email address to receive an email when new articles are posted on . Patients with focal nonmotor seizures experienced a delay from first seizure to diagnosis that was 10 times ...

Analyst Myles Minter noted that the company’s pivotal Phase III study of BHV-7000 in focal-onset epilepsy in the first half ...

Introduction: Botulinum toxin (BTX) has been used to treat muscle overactivity and can reduce pain from muscle spasm. There are no previous reports to our knowledge of using BTX to treat the pain from ...

In focal epilepsy, seizures are generated by a localized, synchronous neuronal electrical discharge that may spread to large portions of the brain. In spite of intense research in the field of ...

University of California San Diego is conducting new, Phase 2/3 national epilepsy clinical research trials, called Rise, to study BHV-7000, a novel investigational therapy, in focal epilepsy.

Dear Dr. Roach: Yesterday, my right hand started shaking uncontrollably. It did not stop for two hours. My left hand has had issues for years, shaking mostly when reading the paper or holding ...

Patients with focal nonmotor seizures experience a "disproportionate delay to diagnosis" compared with those with focal motor seizures, especially among teens, new research suggests. Retrospective ...

DEAR DR. ROACH: Yesterday, my right hand started shaking uncontrollably. It did not stop for two hours. Earlier this year, I found that it shook whenever I tried to write, and I had to utilize a ...